Mycophenolate mofetil (MMF)/mycophenolic acid (MPA) - Important Safety Information from Roche Products (Ireland) Limited, Novartis Ireland Limited, Teva, Accord Healthcare Limited, Clonmel Healthcare Ltd. and Rowex Ltd.as approved by the HPRA

Notice type: 3rd Party Publications

Date: 23/01/2018

 

Problem Or Issue:

Important Safety Information communication from Roche Products (Ireland) Limited, Novartis Ireland Limited, Teva, Accord Healthcare Limited, Clonmel Healthcare Ltd. and Rowex Ltd.on mycophenolate mofetil (MMF)/mycophenolic acid (MPA): amended recommendations for contraception.


Important Safety Information - mycophenolate mofetil (MMF)mycophenolic acid (MPA)


 



« Back